Snowflake director sells 300K shares around $330
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Snowflake Inc. (SNOW) director Frank Slootman reported exercising stock options for 300,000 shares of common stock at an exercise price of $8.88 per share on September 18 and 21, 2026, and selling 300,000 shares in multiple open-market transactions at prices around the low-to-mid $330s. These exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025, and some additional shares are held indirectly through various trusts for which he or his spouse serves as trustee.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F25 | 102,791 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 102,791 | $8.88 | $913K |
| Sale | Common Stock F1, F10, F2 | 1,936 | $330.165 | $639K |
| Sale | Common Stock F1, F11, F2 | 2,268 | $331.181 | $751K |
| Sale | Common Stock F1, F12, F2 | 6,671 | $332.261 | $2.22M |
| Sale | Common Stock F1, F13, F2 | 5,740 | $333.465 | $1.91M |
| Sale | Common Stock F1, F14, F2 | 25,159 | $334.349 | $8.41M |
| Sale | Common Stock F1, F15, F2 | 25,268 | $335.081 | $8.47M |
| Sale | Common Stock F1, F16, F2 | 9,843 | $336.293 | $3.31M |
| Sale | Common Stock F1, F17, F2 | 15,867 | $337.237 | $5.35M |
| Sale | Common Stock F1, F18, F2 | 7,529 | $338.121 | $2.55M |
| Sale | Common Stock F1, F19, F2 | 2,510 | $338.994 | $851K |
| Exercise | Stock Option (Right to Buy) F1, F25 | 197,209 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 197,209 | $8.88 | $1.75M |
| Sale | Common Stock F1, F3, F2 | 15,187 | $331.352 | $5.03M |
| Sale | Common Stock F1, F4, F2 | 23,507 | $332.189 | $7.81M |
| Sale | Common Stock F1, F5, F2 | 79,366 | $333.269 | $26.45M |
| Sale | Common Stock F1, F6, F2 | 42,009 | $334.24 | $14.04M |
| Sale | Common Stock F1, F7, F2 | 2,841 | $335.228 | $952K |
| Sale | Common Stock F1, F8, F2 | 4,097 | $336.107 | $1.38M |
| Sale | Common Stock F1, F2 | 102 | $337.05 | $34K |
| Sale | Common Stock F1, F9, F2 | 30,100 | $338.609 | $10.19M |
| Holding | Common Stock F20 | -- | -- | -- |
| Holding | Common Stock F21 | -- | -- | -- |
| Holding | Common Stock F22 | -- | -- | -- |
| Holding | Common Stock F23 | -- | -- | -- |
| Holding | Common Stock F24 | -- | -- | -- |
Footnotes (25)
- F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
- F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.745 to $331.740, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
- F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.760 to $332.750, inclusive.
- F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.770 to $333.760, inclusive.
- F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.780 to $334.775, inclusive.
- F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.785 to $335.770, inclusive.
- F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.800 to $336.480, inclusive.
- F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.250 to $338.610, inclusive.
- F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive.
- F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive.
- F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive.
- F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive.
- F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive.
- F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive.
- F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive.
- F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive.
- F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive.
- F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive.
- F20. The shares are held by the Slootman Living Trust dated 9/8/1999 for which the Reporting Person is a trustee.
- F21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
- F22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
- F23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
- F24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
- F25. The stock option is fully vested.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted-average price financial
restricted stock units financial
Grantor Retained Annuity Trust financial
Living Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Snowflake (SNOW) director Frank Slootman report in this Form 4?
What stock options did Frank Slootman exercise in Snowflake (SNOW)?
Were Frank Slootman’s SNOW transactions made under a Rule 10b5-1 plan?
What are the key dates of the Snowflake (SNOW) insider transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.